Preclinical studies analyzing the consequences of PDE4 blockade on AAA expansion had not been previously carried out, although the inhibition of PDE4 activity limits the progression of cerebral aneurysms [39], a disorder which shares some pathological characteristics with AAA, such as ECM proteolysis and inflammation. Here, PDE4A is linked to triple-A syndrome.